titanium dioxide has been researched along with Coronary Restenosis in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, Y; Cho, KH; Han, X; Hong, YJ; Hyun, DY; Jeong, MH; Kim, J; Kim, JH; Kim, M; Kim, MC; Park, DS; Park, JK; Sim, DS | 1 |
| Cherian, AM; Joseph, J; Menon, D; Nair, MB; Nair, SV; Vijayakumar, M | 1 |
| Bae, IH; Hong, YJ; Jang, EJ; Jeong, MH; Kim, HB; Lee, SY; Lim, HC; Lim, KS; Park, DS; Park, JK; Shim, JW; Sim, DS | 1 |
| Gu, Z; Rolfe, BE; Thomas, AC; Xu, ZP | 1 |
| Ahn, Y; Bae, IH; Cho, DL; Hong, YJ; Jeong, HY; Jeong, MH; Kim, HS; Kim, JH; Kim, JM; Kim, YS; Lim, KS; Park, DS; Park, JK; Park, KH; Sim, DS; Song, SJ; Yang, EJ | 1 |
| Chen, X; Huo, Y; Li, H; Li, W; Li, Z; Lu, C; Lu, Q; Lyu, S; Song, X; Wang, D; Wang, L; Xu, B; Yuan, F; Zhang, Z | 1 |
| Ahn, Y; Bae, IH; Hong, YJ; Hyun, DY; Jeong, MH; Kang, JC; Kim, JH; Lee, JH; Lim, KS; Park, DS; Sim, DS; Yang, HY; Zhehao, P | 1 |
| Huang, N; Li, Z; Yang, K; Zhang, B; Zhang, H; Zhao, A; Zhao, H | 1 |
1 review(s) available for titanium dioxide and Coronary Restenosis
| Article | Year |
|---|---|
Restenosis treatments using nanoparticle-based drug delivery systems.
Topics: Animals; Coronary Restenosis; Drug Delivery Systems; Drug Design; Humans; Liposomes; Nanoparticles; Nanotubes; Polymers; Proteins; Titanium | 2013 |
1 trial(s) available for titanium dioxide and Coronary Restenosis
| Article | Year |
|---|---|
Novel completed biodegradable polymer sirolimus-eluting stent versus durable polymer sirolimus-eluting stent in de novo lesions: nine-month angiographic and three-year clinical outcomes of HOPE trial.
Topics: Adult; Aged; Angiography; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Humans; Middle Aged; Percutaneous Coronary Intervention; Polymers; Sirolimus; Titanium; Treatment Outcome; Young Adult | 2014 |
6 other study(ies) available for titanium dioxide and Coronary Restenosis
| Article | Year |
|---|---|
Preclinical Evaluation of a Novel Polymer-free Everolimus-eluting Stent in a Mid-term Porcine Coronary Restenosis Model.
Topics: Animals; Coronary Angiography; Coronary Restenosis; Coronary Vessels; Disease Models, Animal; Drug Evaluation, Preclinical; Drug-Eluting Stents; Everolimus; Polymers; Swine; Swine, Miniature; Titanium; Tomography, Optical Coherence | 2021 |
Coupled benefits of nanotopography and titania surface chemistry in fostering endothelialization and reducing in-stent restenosis in coronary stents.
Topics: Animals; Coronary Restenosis; Drug-Eluting Stents; Polymers; Rabbits; Stents; Titanium | 2022 |
In vitro and in vivo evaluation of a novel polymer-free everolimus-eluting stent by nitrogen-doped titanium dioxide film deposition.
Topics: Animals; Cell Proliferation; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Everolimus; Myocytes, Smooth Muscle; Nitrogen; Platelet Adhesiveness; Platelet Aggregation; Polymers; Spectroscopy, Fourier Transform Infrared; Surface Properties; Sus scrofa; Titanium; Tomography, Optical Coherence | 2018 |
Effect of polymer-free TiO2 stent coated with abciximab or alpha lipoic acid in porcine coronary restenosis model.
Topics: Abciximab; Animals; Antibodies, Monoclonal; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Fibrin; Hyperplasia; Immunoglobulin Fab Fragments; Inflammation; Male; Neointima; Percutaneous Coronary Intervention; Polymers; Swine; Thioctic Acid; Time Factors; Titanium; Treatment Outcome | 2014 |
A novel polymer-free drug-eluting stent coated with everolimus using nitrogen-doped titanium dioxide film deposition in a porcine coronary restenosis model.
Topics: Animals; Coronary Restenosis; Disease Models, Animal; Drug-Eluting Stents; Everolimus; Nitrogen; Polymers; Prosthesis Design; Random Allocation; Swine; Titanium | 2016 |
[Anti-restenosis study on a new drug eluting stent].
Topics: Angioplasty, Balloon, Coronary; Animals; Coated Materials, Biocompatible; Coronary Restenosis; Drug-Eluting Stents; Random Allocation; Swine; Swine, Miniature; Titanium | 2008 |